Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antivenom for Bungarus Multicinctus Envenoming
NCT00811239Phase 2Completed
- Sponsor
- Hanoi Medical University
- Start
- Mar 2004
- Primary completion
- Dec 2006
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of Bungarus multicinctus-candidus Antivenom in snakebite (2 arms), sponsored by Hanoi Medical University. Primary endpoint: Duration of mechanical ventilation. Started Mar 2004; status: completed.
02
Drugs
Bungarus multicinctus-candidus Antivenom
03
Conditions
snakebite
Beyond the preview
Go deeper on NCT00811239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811239.